The OpenAI CEO is adding a well-funded brain-computer interface startup to his growing portfolio of ambitious bets.

A new, high-performance brain-computer interface (BCI) can be rapidly implanted through a minimally invasive procedure. The new BCI solution has been implanted in over 50 patients.

LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

Merge Labs is a “research lab” dedicated to “bridging biological and artificial intelligence to maximize human ability.” ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

The man is enrolled in the BrainGate2 clinical trial at UC Davis Health. His ability to communicate through a computer has ...

OpenAI leads a major seed round in Sam Altman’s Merge Labs to develop advanced, non-invasive brain-computer interfaces with ...

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

Signal Enhancement: An acoustic-driven signal enhancement approach based on NeRF acoustic field modeling and nested generative networks supplements missing or incomplete EEG data through acoustic ...

OpenAI has signaled its intentions to become a major player in brain computer interfaces (BCIs) with a $252 million ...

OpenAI (OPENAI) announced on Thursday that it has invested in brain computer interface startup Merge Labs, which includes ...